Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors

Blood. 1993 Aug 1;82(3):800-6.

Abstract

The effect of human fibrinogen on the proliferation of purified SBA- CD34+ human bone marrow progenitors was investigated in clonal cultures. Fibrinogen alone or in combination with erythropoietin had no significant effect. However, in the presence of recombinant human interleukin-3 (IL-3), fibrinogen increased significantly in a dose-dependent manner the number of mixed and burst-forming unit-ethrocyte--derived colonies, whereas the number of other colonies did not significantly change. In the presence of fibrinogen, low concentrations of IL-3 (0.17 U/mL) produced three times more mixed colonies than without fibrinogen, reaching the number of colonies obtained with optimal concentrations of IL-3 (1.67 U/mL). Fibrinogen fragment D had the same effect in the presence of IL-3 as intact fibrinogen, whereas fibrinogen fragment E and human collagen IV did not. This effect was not mediated by integrins, because peptides or monoclonal antibodies that block fibrinogen binding on integrins alpha IIb beta 3, alpha v beta 3 (RGD-peptides), alpha m beta 2 (OKM-1), and alpha x beta 2 (HC1/1) did not affect the observed mitogenic effect. The mitogenic effect of fibrinogen and its D fragment was not mediated by induction of IL-6 or granulocyte--colony-stimulating factor secretion, because it was not inhibited by blocking antisera against these two growth factors. Our results indicate that fibrinogen potentiates the effect of IL-3 on primitive hematopoietic progenitors and suggest that the mitogenic effect of fibrinogen could be mediated via a specific mitogenic receptor that does not belong to the integrin family.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Bone Marrow Cells*
  • Cell Division / drug effects
  • Cells, Cultured
  • Drug Synergism
  • Erythropoietin / pharmacology
  • Fibrinogen / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Hematopoiesis / drug effects*
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • In Vitro Techniques
  • Integrins / physiology
  • Interleukin-3 / administration & dosage*
  • Interleukin-6 / metabolism
  • Molecular Sequence Data
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology

Substances

  • Integrins
  • Interleukin-3
  • Interleukin-6
  • Oligopeptides
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Fibrinogen